×
About 158 results

ALLMedicine™ Peripheral Ulcerative Keratitis Center

Research & Reviews  58 results

Clinical Profile and Treatment Outcomes of Patients With Acremonium Species Positive Ke...
https://doi.org/10.1097/ICL.0000000000000902
Eye & Contact Lens; Maharana PK, Saluja G et. al.

Jun 16th, 2022 - To report the clinical profile and treatment outcomes of patients with culture-positive Acremonium keratitis. This is a retrospective observational study. Medical records of all patients treated in a tertiary eye hospital for culture positive infe...

Visual Outcomes of Patients With Peripheral Ulcerative Keratitis and the Effect of Immu...
https://doi.org/10.1097/ICL.0000000000000906
Eye & Contact Lens; Li Y, McKelvie J et. al.

May 18th, 2022 - Peripheral ulcerative keratitis (PUK) can cause significant ocular morbidity and mortality. This study aimed to review the effects of systemic immunosuppression on visual outcomes. A state-wide, retrospective case series based in Queensland, Austr...

Evaluation of the SUN Classification Criteria for Uveitides in an Academic Uveitis Prac...
https://doi.org/10.1016/j.ajo.2022.04.007
American Journal of Ophthalmology; Mudie LI, Reddy AK et. al.

Apr 27th, 2022 - To evaluate the new Standardization of Uveitis Nomenclature (SUN) classification criteria for uveitides by applying them to patients in an academic uveitis practice. Evaluation of classification criteria. The charts of all patients attending the u...

Bilateral Peripheral Ulcerative Keratitis Associated with Dupilumab.
https://doi.org/10.1016/j.ophtha.2021.11.002
Ophthalmology Far PM, Quinn MP et. al.

Apr 25th, 2022 - Bilateral Peripheral Ulcerative Keratitis Associated with Dupilumab.|2022|Far PM,Quinn MP,Johnson D,|adverse effects,chemically induced,diagnosis,drug therapy,

Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early im...
https://doi.org/10.1136/bjophthalmol-2022-321132
The British Journal of Ophthalmology; Ruiz-Lozano RE, Ramos-Davila EM et. al.

Apr 15th, 2022 - To evaluate the role of early immunosuppressive therapy (IMT) in the management of rheumatoid arthritis (RA)-associated peripheral ulcerative keratitis (PUK). Single-centre, retrospective, comparative cohort study. Patients with RA-associated PUK ...

see more →

Clinicaltrials.gov  3 results

AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients
https://clinicaltrials.gov/ct2/show/NCT04873739

Feb 3rd, 2022 - Systemic lupus erythematous (SLE) is a relapsing and remitting autoimmune connective tissue disorder that can affect many organs such as skin, joints, kidneys, eye, and brain (1) . SLE has a global prevalence of 0.3 to 23.2 cases per 100,000. Wome...

AS-OCT Study of Cornea and Tear Film Parameters in Juvenile SLE Patients
https://clinicaltrials.gov/ct2/show/NCT05015465

Aug 20th, 2021 - Juvenile systemic lupus erythematous (SLE) is a relapsing and remitting autoimmune connective tissue disorder that can affect many organs such as skin, joints, kidneys, eye, and brain (1) . SLE has a global prevalence of 0.3 to 23.2 cases per 100,...

Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)
https://clinicaltrials.gov/ct2/show/NCT03088293

Jul 14th, 2020 - This study will evaluate the Efficacy and Safety of Infliximab versus Cyclophosphamide in Subjects with Idiopathic Refractory Scleritis. The term scleritis describes a chronic inflammation that involves the outermost cost and skeleton of the eye. ...

see more →

News  2 results

Filamentary Keratitis as a Presenting Sign
https://www.medscape.com/viewarticle/839162_2

Feb 5th, 2015 - Differential Diagnosis Opportunistic bacterial infection was considered but deemed unlikely in this case because of a lack of significant corneal infiltrate or mucopurulent discharge. Herpes simplex keratitis is typically unilateral. Mooren's ulce...

Case: Biologic Effective in Refractory Necrotizing Scleritis
https://www.mdedge.com/rheumatology/article/44084/rheumatoid-arthritis/case-biologic-effective-refractory-necrotizing
Nancy Walsh

GLASGOW, SCOTLAND — Treatment with a biologic agent may be life- and sight-saving in cases of refractory necrotizing scleritis, as was the case for a 60-year-old man with a 10-year history of rheumatoid arthritis and a 2-week history of red, painf.

see more →